Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
Provided By GlobeNewswire
Last update: May 1, 2025
- Implementation of cost reduction initiatives to position Pliant for
execution of late-stage clinical trials
- Pliant will reduce its current workforce by approximately 45%
NASDAQ:PLRX (7/25/2025, 3:11:53 PM)
1.585
-0.01 (-0.31%)
Find more stocks in the Stock Screener
